These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32426841)

  • 21. Antibiotic therapeutic drug monitoring in intensive care patients treated with different modalities of extracorporeal membrane oxygenation (ECMO) and renal replacement therapy: a prospective, observational single-center study.
    Kühn D; Metz C; Seiler F; Wehrfritz H; Roth S; Alqudrah M; Becker A; Bracht H; Wagenpfeil S; Hoffmann M; Bals R; Hübner U; Geisel J; Lepper PM; Becker SL
    Crit Care; 2020 Nov; 24(1):664. PubMed ID: 33239110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of inoculum size on selection of in vitro resistance to vancomycin, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.
    Rio-Marques L; Hartke A; Bizzini A
    Microb Drug Resist; 2014 Dec; 20(6):539-43. PubMed ID: 25010140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of methicillin-resistant Staphylococcus aureus osteomyelitis with combination therapy using linezolid and rifampicin under therapeutic drug monitoring.
    Ashizawa N; Tsuji Y; Kawago K; Higashi Y; Tashiro M; Nogami M; Gejo R; Narukawa M; Kimura T; Yamamoto Y
    J Infect Chemother; 2016 May; 22(5):331-4. PubMed ID: 26732509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of area under the concentration-time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia.
    Song KH; Kim HB; Kim HS; Lee MJ; Jung Y; Kim G; Hwang JH; Kim NH; Kim M; Kim CJ; Choe PG; Chung JY; Park WB; Kim ES; Park KU; Kim NJ; Kim EC; Oh MD
    Int J Antimicrob Agents; 2015 Dec; 46(6):689-95. PubMed ID: 26555059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of tricuspid valve endocarditis with daptomycin and linezolid therapy.
    Galanter KM; Ho J
    Am J Health Syst Pharm; 2019 Jul; 76(14):1033-1036. PubMed ID: 31201773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subtherapeutic linezolid concentrations in a patient with morbid obesity and methicillin-resistant Staphylococcus aureus pneumonia: case report and review of the literature.
    Muzevich KM; Lee KB
    Ann Pharmacother; 2013 Jun; 47(6):e25. PubMed ID: 23673532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia.
    Jung Y; Song KH; Cho Je; Kim HS; Kim NH; Kim TS; Choe PG; Chung JY; Park WB; Bang JH; Kim ES; Park KU; Park SW; Kim HB; Kim NJ; Oh MD
    Int J Antimicrob Agents; 2014 Feb; 43(2):179-83. PubMed ID: 24315788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linezolid minimum inhibitory concentration (MIC) creep in methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates at a single Japanese center.
    Miyazaki M; Nagata N; Miyazaki H; Matsuo K; Takata T; Tanihara S; Kamimura H
    Biol Pharm Bull; 2014; 37(4):679-82. PubMed ID: 24694615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetics/pharmacodynamics of linezolid in sepsis patients with and without continuous renal replacement therapy.
    Ide T; Takesue Y; Ikawa K; Morikawa N; Ueda T; Takahashi Y; Nakajima K; Takeda K; Nishi S
    Int J Antimicrob Agents; 2018 May; 51(5):745-751. PubMed ID: 29425834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective Cohort Study of Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Adults on Extracorporeal Membrane Oxygenation.
    Jung Y; Lee DH; Kim HS
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33257444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic/pharmacodynamic evaluation of linezolid for the treatment of staphylococcal infections in critically ill patients.
    Dong H; Xie J; Wang T; Chen L; Zeng X; Sun J; Wang X; Dong Y
    Int J Antimicrob Agents; 2016 Sep; 48(3):259-64. PubMed ID: 27474469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transfer of linezolid into breast milk.
    Rowe HE; Felkins K; Cooper SD; Hale TW
    J Hum Lact; 2014 Nov; 30(4):410-2. PubMed ID: 25098610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of linezolid during continuous hemodiafiltration: A case report.
    Yamashina T; Tsuruyama M; Odawara M; Tsuruta M; Miyata H; Kozono A; Tsuji Y; Miyoshi T; Kawamata Y; Hiraki Y
    J Infect Chemother; 2017 Oct; 23(10):709-712. PubMed ID: 28408302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting effects of antibiotic combinations using MICs determined at pharmacokinetically derived concentration ratios: in vitro model studies with linezolid- and rifampicin-exposed Staphylococcus aureus.
    Golikova MV; Strukova EN; Portnoy YA; Dovzhenko SA; Kobrin MB; Zinner SH; Firsov AA
    J Chemother; 2017 Oct; 29(5):267-273. PubMed ID: 28192070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia.
    Fukumori S; Tsuji Y; Mizoguchi A; Kasai H; Ishibashi T; Iwamura N; To H
    J Clin Pharm Ther; 2016 Aug; 41(4):399-402. PubMed ID: 27144370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vancomycin, teicoplanin, daptomycin, and linezolid MIC creep in methicillin-resistant Staphylococcus aureus is associated with clonality.
    Hsieh YC; Lin YC; Huang YC
    Medicine (Baltimore); 2016 Oct; 95(41):e5060. PubMed ID: 27741120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Neonates on Extracorporeal Life Support.
    Cies JJ; Moore WS; Nichols K; Knoderer CA; Carella DM; Chopra A
    Pediatr Crit Care Med; 2017 Oct; 18(10):977-985. PubMed ID: 28650363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The safety and efficacy of linezolid and daptomycin as an additive in Optisol-GS against methicillin-resistant Staphylococcus aureus.
    Li J; Feiz V; Vieira AC; Davis-Boozer D; Polage C
    Cornea; 2012 May; 31(5):551-8. PubMed ID: 22378113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.
    Frymoyer A; Guglielmo BJ; Hersh AL
    Pediatr Infect Dis J; 2013 Oct; 32(10):1077-9. PubMed ID: 23652479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linezolid dosage in pediatric patients based on pharmacokinetics and pharmacodynamics.
    Matsumoto K; Shigemi A; Takeshita A; Watanabe E; Yokoyama Y; Ikawa K; Morikawa N; Takeda Y
    J Infect Chemother; 2015 Jan; 21(1):70-3. PubMed ID: 25305808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.